Q5104 Injection, renflexis
Also known as: Renflexis injection, infliximab-abda
Injection of Renflexis, infliximab-abda biosimilar, for treatment of inflammatory diseases.
In Plain Language
anti-TNF injectable; inflammation-reducing drug
Clinical Context
Indicated for rheumatoid arthritis, inflammatory bowel disease, psoriasis, and ankylosing spondylitis.
RVU Information
CPT Q5104 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5104?
CPT Q5104 (Injection, renflexis) is a Q Codes code. Injection of Renflexis, infliximab-abda biosimilar, for treatment of inflammatory diseases.
Is Q5104 covered by insurance?
Q5104 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Indicated for rheumatoid arthritis, inflammatory bowel disease, psoriasis, and ankylosing spondylitis.
When is CPT Q5104 used?
Indicated for rheumatoid arthritis, inflammatory bowel disease, psoriasis, and ankylosing spondylitis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.